Medial Patellofemoral Ligament Reconstruction
4
2
2
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
5 treatments under study, led by Bupivacaine Dexamethasone In Anterior Femoral Cutaneous Nerve Block
Research Leaders
6 sponsors active, led by University of Utah
Related Conditions
Often studied with 5 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 4 trials
100.0%
+13.4% vs benchmark
25%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (4)
Medial Patellofemoral Ligament Reconstruction in Children - a 2-8 Years Follow-up Study
Anterior Femoral and Adductor Canal Nerve Blocks in Peds Knees
SHould You TransFer the Tubercle?
Medial Patellofemoral Ligament Reconstruction: A Review of Technique, Accuracy, and Outcome
Research Network
Common Treatments
- Bupivacaine Dexamethasone In Anterior Femoral Cutaneous Nerve Block1
- Tibial Tubercle Osteotomy1
- Medial Patellofemoral Ligament Reconstruction1
- Bupivacaine Dexamethasone In Adductor Canal Block1
- Mpflreconstruction1
Active Sponsors
- University of Utah1
- Canadian Orthopaedic Foundation1
- Aarhus University Hospital1
- Banff Sport Medicine Foundation1
- CONMED Corporation1
Top Investigators
University of Utah Orthopaedic Center
University of Calgary
Hospital for Special Surgery, New York
Related Conditions
- Anterior Cruciate Ligament Reconstruction1
- Healthy1
- Tibial Tubercle Osteotomy1
- Medial Patellofemoral Dislocation1
- Patellofemoral Dislocation1